Pirtobrutinib and Venetoclax With MRD Detection for Previously Untreated Chronic Lymphocytic Leukemia
Clinical trial NCT05677919 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05677919
- Sponsor
- Mayo Clinic
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-31
- Primary completion
- 2026-11-11
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.